Kamunting Street Capital Management, L.P. Bausch Health Companies Inc. Transaction History

Kamunting Street Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $534,250 - $859,500	25,000 New	25,000 $794,000
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $205,200 - $264,500	-10,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $202,300 - $262,900	10,000 New	10,000 $247,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.